[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 42, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 41, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 52, "title": "Chief People Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.62, "open": 6.5, "dayLow": 5.98, "dayHigh": 6.95, "regularMarketPreviousClose": 6.62, "regularMarketOpen": 6.5, "regularMarketDayLow": 5.98, "regularMarketDayHigh": 6.95, "payoutRatio": 0.0, "beta": 0.461, "forwardPE": -4.2012196, "volume": 2017894, "regularMarketVolume": 2017894, "averageVolume": 1906919, "averageVolume10days": 1071000, "averageDailyVolume10Day": 1071000, "bid": 6.83, "ask": 6.95, "bidSize": 1, "askSize": 1, "marketCap": 435714624, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 33.99, "allTimeLow": 1.0, "fiftyDayAverage": 6.7352, "twoHundredDayAverage": 3.4316, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 227882128, "profitMargins": 0.0, "floatShares": 25229271, "sharesOutstanding": 63238699, "sharesShort": 7692365, "sharesShortPriorMonth": 2958155, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1216, "heldPercentInsiders": 0.19955999, "heldPercentInstitutions": 0.35597, "shortRatio": 2.35, "shortPercentOfFloat": 0.14050001, "impliedSharesOutstanding": 63238699, "bookValue": 0.804, "priceToBook": 8.569652, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -62128864, "trailingEps": -1.9, "forwardEps": -1.64, "enterpriseToEbitda": -3.577, "52WeekChange": 2.4842105, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 6.89, "targetHighPrice": 30.0, "targetLowPrice": 11.0, "targetMeanPrice": 16.66667, "targetMedianPrice": 13.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 26355498, "totalCashPerShare": 0.726, "ebitda": -63700328, "totalDebt": 4000560, "quickRatio": 3.52, "currentRatio": 3.703, "debtToEquity": 13.826, "returnOnAssets": -0.68372, "returnOnEquity": -1.3046601, "freeCashflow": -29878488, "operatingCashflow": -51509300, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1762563106, "regularMarketTime": 1762549201, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "earningsCallTimestampStart": 1762808400, "earningsCallTimestampEnd": 1762808400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.9, "epsForward": -1.64, "epsCurrentYear": -1.585, "priceEpsCurrentYear": -4.347003, "fiftyDayAverageChange": 0.15479994, "fiftyDayAverageChangePercent": 0.022983719, "twoHundredDayAverageChange": 3.4583998, "twoHundredDayAverageChangePercent": 1.0078096, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 4.07855, "regularMarketPrice": 6.89, "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 1.0116146, "postMarketPrice": 6.9597, "postMarketChange": 0.06970024, "regularMarketChange": 0.27, "regularMarketDayRange": "5.98 - 6.95", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1906919, "fiftyTwoWeekLowChange": 5.79, "fiftyTwoWeekLowChangePercent": 5.263636, "fiftyTwoWeekRange": "1.1 - 10.08", "fiftyTwoWeekHighChange": -3.19, "fiftyTwoWeekHighChangePercent": -0.31646827, "fiftyTwoWeekChangePercent": 248.42105, "earningsTimestamp": 1762981200, "marketState": "CLOSED", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]